Suchergebnisse - "Sacher, Adrian G"

PubPharm (59)

1

Generation of an Inhibitory NK Cell Subset by TGF-β1/IL-15 Polarization

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2024

von Chung, D. | Garcia-Batres, C. | Millar, D. | +11

2

Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma : a multicentre retrospective cohort study

enthalten in: BMJ open | 2024

von Labidi, S. | Meti, N. | Barua, R. | +11

3

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

enthalten in: Nature communications | 2024

von Middha, P. | Thummalapalli, R. | Betti, M. | +30

UpdateOf: medRxiv. 2023 Sep 13;:. - PMID 37292751

4

Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations : Efficacy and Toxicity as Sequential Therapies

enthalten in: JTO clinical and research reports | 2023

von Lau, S. | Perdrizet, K. | Fung, A. | +14

5

Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma

enthalten in: bioRxiv.org | 2023

von Labidi, S. | Meti, N. | Barua, R. | +11

6

Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer : The ACCELERATE Nonrandomized Clinical Trial

enthalten in: JAMA network open | 2023

von García-Pardo, M. | Czarnecka-Kujawa, K. | Law, J. | +26

7

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Small-Cell Lung Cancer : 2-Year Analysis of CodeBreaK 100

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Dy, G. | Govindan, R. | Velcheti, V. | +21

8

Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence

enthalten in: Cancer treatment and research communications | 2023

von Esfahanian, N. | Chan, S. | Zhan, L. | +16

9

Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2023

von Schmid, S. | Cheng, S. | Chotai, S. | +16

10

PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2022

von Lau, S. | Rabindranath, M. | Weiss, J. | +19

1
2
3
4
5
6
Nächster »
[6]